©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Exposure of B-lineage Lymphoid Cells to Low Energy Electromagnetic Fields Stimulates Lyn Kinase (*)

(Received for publication, April 13, 1995; and in revised form, July 18, 1995)

Fatih M. Uckun (1)(§) Tomohiro Kurosaki (2) Jizhong Jin (1) Xiao Jun (1) Andre Morgan (4) Minoru Takata (2) Joseph Bolen (3) Richard Luben (4)

From the  (1)Molecular Biochemistry Laboratory, Biotherapy Program, Departments of Therapeutic Radiology-Radiation Oncology, Pharmacology and Pediatrics, University of Minnesota Health Sciences Center, Minneapolis, Minnesota 55455, the (2)Department of Cardiovascular Molecular Biology, Lederle Laboratories, Pearl River, New York 10965, the (3)Signal Transduction Laboratory, Department of Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543, and the (4)Division of Biomedical Sciences, University of California, Riverside, California 95251

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Here, we present evidence that exposure of B-lineage lymphoid cells to low energy electromagnetic fields (EMF) stimulates the protein tyrosine kinases Lyn and Syk, results in tyrosine phosphorylation of multiple electrophoretically distinct substrates, and leads to downstream activation of protein kinase C (PKC). EMF exposure enhances protein tyrosine phosphorylation in Syk deficient but not in Lyn-deficient B-lineage lymphoid cells and stimulates Lyn kinase activity in wild-type as well as Syk-deficient B-lineage lymphoid cells. These results indicate that activation of Lyn kinase is sufficient and mandatory for EMF-induced tyrosine phosphorylation in B-lineage lymphoid cells. The PKC activity increases later than the Lyn activity and pretreatment with the PTK inhibitors genistein or herbimycin A abrogates the EMF-induced PKC signal. Thus, stimulation of Lyn is a proximal and mandatory step in EMF-induced activation of PKC in B-lineage lymphoid cells. Our observations prompt the hypothesis that a delicate growth regulatory balance might be altered in B-lineage lymphoid cells by EMF-induced activation of Lyn.


INTRODUCTION

B-lineage acute lymphoblastic leukemia (ALL) (^1)is the most common form of childhood cancer(1, 2) . B-lineage ALL is a heterogeneous group of diseases that are thought to originate from putative developmental lesions in normal B-lymphocyte precursor clones during early phases of ontogeny, which allegedly lead to maturational arrest at discrete stages of lymphopoiesis. It is generally believed that such developmental lesions lead to an uncoupling of proliferation and differentiation in target lymphocyte precursor clones(1, 2) . The stabilization and subsequent clonal expansion of usually transient B-lymphocyte precursor cell phenotypes have been proposed as critical proximal events in the leukemogenesis of B-lineage ALL(1, 2, 3) .

Recently, concern has emerged about the possibility that EMF radiation from residentially proximate power lines, household electrical wiring, and appliance usage may contribute to the risk of childhood ALL (4, 5, 6, 7, 8, 9, 10, 11, 12) . Several studies of associations between childhood leukemia and residential exposure to EMF from electric power lines yielded epidemiologic evidence for a link between EMF exposure and ALL(4, 5, 6, 7, 8, 9, 10, 11, 12, 13) . A recent study by the Swedish National Institute for Occupational Health indicated that children in Sweden chronically exposed to powerline frequency magnetic fields exhibited a 3-fold increase in their incidence of leukemia(14) , and similar data have been reported by other investigators(14, 15, 16, 17, 18, 19, 20) .

The molecular mechanism by which EMF exposure could participate in the complex process leading from changes in cell properties to the actual development of B-lineage ALL in vivo has not been deciphered. No directly genotoxic actions of low energy EMF are known, and it is widely agreed that exposure of cells to nonionizing EMF does not produce mutations or chromosome damage(17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27) . Thus, any participation by EMF in leukemogenesis of B-lineage ALL is likely to be by means of influencing survival, proliferation, and/or differentiation of B-lineage lymphoid cells rather than by producing the primary mutational or ``initiation'' event. A point of exceptional experimental focus in current EMF research is the investigation of EMF effects on signal transduction pathways(28, 29, 30, 31, 32, 33, 34) . Several investigators noted that EMF exposure activates a protein kinase C (PKC)-linked signaling cascade(34, 35) . However, EMF-induced signaling events proximal to PKC activation have not been evaluated.

Protein tyrosine kinases (PTK) participate and play pivotal and myriad roles in initiation of signal cascades that affect proliferation and survival of human B-lineage lymphoid cells(36, 37, 38, 39, 40, 41, 42, 43) . Notably, recent studies indicate that stimulation of protein tyrosine kinases in B-lymphocyte precursors is a requisite step in the generation of the pleiotropic effects of ionizing radiation, including the activation of protein kinase C (PKC) and PKC-dependent serine kinases, nuclear factor kappa B (NF-kappaB), as well as c-jun proto-oncogene expression(36, 37, 38) . A delicate balance of oncogenic versus tumor-suppressive proteins might be altered when a tyrosine kinase regulatory pathway is activated(44) .

The purpose of this study was to examine the role of PTK in EMF-induced activation of the PKC pathway in B-lineage lymphoid cells. Here, we present evidence that stimulation of PTK is an important and mandatory proximal step in EMF-induced activation of the PKC signaling cascade in B-lineage lymphoid cells.


EXPERIMENTAL PROCEDURES

Cell Lines

NALM-6 human pre-B cells (39) were maintained in suspension cultures in RPMI 1640 supplemented with 2.5% fetal calf serum, 10 mML-glutamine, and 5 mM pyruvate. Wild-type and mutant DT-40 cells (45, 46) were maintained in suspension cultures at 37 °C, 5% CO(2) in a humidified incubator. The culture medium was RPMI 1640 supplemented with 10% fetal calf serum, 2.5% chicken serum, 10 mML-glutamine, and 50 µM 2-mercaptoethanol.

EMF Exposure and the Use of PTK Inhibitors

Cells (1 times 10^6 cells/ml in RPMI 1640 medium in 75-cm^2 tissue culture flasks) were exposed to a 1-Gauss, 60-Hz EMF field by placing the flasks at the center of the four-coil field generator which was contained in a tissue culture incubator(47, 48) . Control flasks were simultaneously placed inside a duplicate incubator without the exposure apparatus. The ambient 60-Hz magnetic field (i.e. without the exposure apparatus turned on) was measured at leq1 milligauss in both incubators, and the static geomagnetic field was approximately 450 milligauss. Other samples were incubated in the EMF exposure device, with current flowing in antiparallel directions to cancel out the generated magnetic field. Measured 60-Hz magnetic field in the exposure device under these ``sham treatment'' conditions was leq2 milligauss. For all experimental conditions, cells were allowed to equilibrate for at least 2 h before the exposure coils were activated. After exposure for the time periods indicated, flasks were immediately immersed in ice water for 30 s-1 min. Cells were removed from the flasks and spun down at 3,000 times g for 5 min at 0 °C. For immune complex kinase assays, cell pellets were snap-frozen by immersion in liquid nitrogen. For PKC assays, cell pellets were washed with ice-cold phosphate-buffered saline, and the washed pellet was sonicated in ice-cold lysate buffer (20 mM Tris, pH 7.5, 0.5 mM EDTA, 0.5 mM EGTA, 0.5% Triton X-100, and 25 µg/ml each aprotinin and leupeptin). The suspensions were cleared of cellular debris by centrifugation for 1 min at 500 times g. The sonicated suspensions were then centrifuged at 100,000 times g to separate particulate (=membrane) from soluble (=cytoplasm) fractions. The particulate fraction (=100,000 times g pellet) was resuspended by sonication in 20 mM Tris, pH 7.5, 0.5 mM EDTA, 0.5 mM EGTA, 10 mM beta-mercaptoethanol, and 0.2 M NaCl.

Anti-phosphotyrosine Immunoblot Analysis of PTK Activation

Phosphorylation of proteins on tyrosine residues was measured at various time points after EMF exposure or after ligation of the CD19 receptor by immunoblotting with an anti-phosphotyrosine antibody, as described previously(36, 39) .

Immune Complex Kinase Assays of Protein Tyrosine Kinases

To evaluate the effects of EMF on the kinase activity of Lyn or Syk, exponentially growing cells (1 times 10^6/ml in culture medium) were treated with EMF and, at the indicated time points after EMF exposure, lysed in a 1% Nonidet P-40 lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 1 mM EDTA) containing 1 mM Na(3)VO(4) and 1 mM sodium molybdate as phosphatase inhibitors, 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride as protease inhibitors. Lysates were spun twice at 12,000 times g for 15 min at 4 °C prior to immunoprecipitation. 200 µg of cell lysates/sample were immunoprecipitated with a rabbit anti-Lyn antibody (2 µl per 200 µg of lysate) or rabbit anti-Syk antibody (2 µl per 200 µg of lysate), and immune complex kinase assays as well as anti-Lyn or anti-Syk Western blot analyses were performed, as described previously(39) .

PKC Assays

PKC activity was measured by incubating aliquots of cytosolic or membrane fractions with [-P]ATP (3000 Ci/mmol, Amersham) in a solution containing (final concentrations) 20 mM Tris, pH 7.5, 20 mM MgCl(2), 1 mM CaCl(2), 20 µM ATP, 10 µM phorbol 12-myristate 13-acetate, and 0.28 mg/ml phosphatidylserine, with 25 µM concentration of a specific peptide substrate for PKC corresponding to sequence positions 4-14 of myelin basic protein, QKRPSQRSKYL(49) , according to published procedures (50) . The 5 min in vitro kinase reaction was stopped by spotting aliquots of the reaction mixture (25 µl) onto phosphocellulose paper. The paper disks were washed three times with 1% (v/v) phosphoric acid and counted by liquid scintillation.


RESULTS AND DISCUSSION

EMF Exposure of B-lineage Lymphoid Cells Induces Enhanced Tyrosine Phosphorylation of Multiple Substrates

To examine the effects of EMF on protein tyrosine phosphorylation in B-lineage lymphoid cells, we first compared the profiles of tyrosine-phosphorylated proteins in whole cell lysates of NALM-6 human pre-B cells, prepared at various time points after exposure to low energy EMF (1 Gauss, 60 Hz), by Western blot analysis using a polyclonal anti-phosphotyrosine antibody. Fig. 1illustrates that EMF exposure of NALM-6 cells results in enhanced tyrosine phosphorylation of constitutively tyrosine-phosphorylated abundant phosphoprotein substrates with apparent molecular masses of 55 kDa, 76 kDa, 95-97 kDa, 120 kDa, 150 kDa, and 190 kDa within 10 min. Tyrosine phosphorylation showed a biphasic course with a slight increase detectable by 1-3 min (=first peak) followed by dephosphorylation between 3 and 5 min, and a rapid induction to maximum levels between 5 and 10 min (=second peak) followed by gradual dephosphorylation. In addition, a 72-kDa protein substrate with minimal baseline tyrosine phosphorylation became markedly tyrosine-phosphorylated after 10 min of EMF exposure (Fig. 1). Similarly, exposure of DT-40 chicken B-cells to EMF causes enhanced tyrosine phosphorylation of the 55-, 72-, 76-, 95-, 120-, and 150-kDa substrates. However, the kinetics of tyrosine phosphorylation was different from the kinetics observed in NALM-6 cells in that tyrosine phosphorylation was monophasic, and maximum tyrosine phosphorylation was observed after a 1-min EMF exposure.


Figure 1: EMF exposure induces tyrosine phosphorylation of multiple electrophoretically distinct substrates in B-lineage lymphoid cells. NALM-6 human pre-B or DT-40 chicken B cells were exposed to 60-Hz EMF for the indicated periods. After EMF exposure, cells were lysed with SDS lysis buffer and boiled. Equivalent amounts of protein were fractionated on 10.5% polyacrylamide gels, transferred to Immobilon-PVDF membranes, and immunoblotted with an anti-phosphotyrosine antibody followed by incubation with I-protein A (1 µCi/ml) and autoradiography for detection of phosphotyrosyl proteins. Controls included unstimulated samples (CON, negative control) as well as samples stimulated with an anti-CD19 times CD19 monoclonal antibody homoconjugate (1 µg/ml times 10 min)(39) . Molecular masses (in kDa) of the phosphotyrosyl protein substrates were calculated from prestained molecular size markers run as standards.



EMF Exposure of B-lineage Lymphoid Cells Stimulates the Activity of the Src Proto-oncogene Family Tyrosine Kinase Lyn

In B-lineage lymphoid cells, CD19 is physically and functionally associated with Src family protein tyrosine kinases (PTK). The engagement of the CD19 receptor with an anti-CD19 monoclonal antibody homoconjugate rapidly activates the associated PTK and results in tyrosine phosphorylation of multiple substrates(39) . The profile of anti-phosphotyrosine reactive protein substrates generated by EMF exposure of NALM-6 cells was essentially identical with that generated by the engagement of the CD19 receptor with an anti-CD19 monoclonal antibody homoconjugate (Fig. 1, left panel). This intimated the possibility that EMF exposure also effects the activation of Src family PTK. To examine whether this might be the case, NALM-6 cells were exposed to EMF (1Gauss, 60 Hz), and the PTK activity of Lyn, which is the predominant Src family tyrosine kinase in NALM-6 cells (see Fig. 2A), was estimated by immune complex protein kinase assays measuring autophosphorylation. As shown in Fig. 2B, EMF exposure lead to rapid stimulation of Lyn kinase activity in NALM-6 cells. This stimulation was evident as early as 30 s after EMF exposure and reached a maximum at 1 min, representing a 4.8-fold increase in PTK activity (i.e. 99,283 cpm/10^7 cells versus 20,898 cpm/10^7 cells). The comparison of the Lyn kinase activities in cells cultured overnight in the absence of EMF versus in the presence of continuous EMF exposure showed a >9-fold higher activity in EMF-treated cells (6,127 cpm versus 55,603 cpm, see the last two lanes of Fig. 2B). The abundance of the enzyme, as estimated by anti-Lyn immunoblotting, did not change during the course of the experiment suggesting altered specific activity (Fig. 2C). Similar results were obtained with NALM-6-UM1 cell line, a NALM-6 subclone which causes disseminated and fatal leukemia when injected into SCID mice (51) as well as the DT-40 chicken B-cell line (data not shown). These results demonstrate that activation of Src family PTK is an integral component of the signal transduction cascade triggered in response to EMF exposure.


Figure 2: Time course of Lyn kinase activation after EMF exposure. A, unstimulated NALM-6 human pre-B cells were lysed in a Nonidet P-40-containing buffer, and equal amounts of lysate (200 µg of protein/reaction mixture) were used for immunoprecipitation and immune complex kinase assays of the indicated Src family PTK, as described under ``Experimental Procedures.'' No primary antibody was added to the lysate of the control sample (first lane from left). B, NALM-6 cells were exposed to 60-Hz EMF for the times indicated, pelleted, lysed in Nonidet P-40 buffer. Lyn kinase was immunoprecipitated, and immune complex kinase assays (39) were performed using half of the samples, as described under ``Experimental Procedures.'' Autophosphorylation was quantitated by a 4-min liquid scintillation counting of the incorporated P in the the excised Lyn kinase bands. C, the other half of the Lyn immunoprecipitates were fractionated first on 9.5% polyacrylamide gels, electrophoretically transferred to Immobilon-polyvinylidene difluoride membranes and immunoblotted for 1 h with anti-Lyn antibody (1:100 dilution) followed by incubation with I-protein A (specific activity = 30 µCi/µg; ICN Biomedicals) and autoradiography for detection of Lyn, as described(39) . Since the anti-Lyn antibody was generated by using a GST-fusion protein of the 56-kDa form of Lyn, it preferentially reacts with p56 in Western blot analyses.



EMF Exposure of B-lineage Lymphoid Cells Stimulates the Activity of Syk Kinase

Syk kinase is a 72-kDa non-receptor PTK which is involved in important physiologic signaling events in B-lineage lymphoid cells, including the B-cell receptor-coupled calcium mobilization(45, 46, 52, 53, 54) . Syk kinase can be activated by several members of the Src PTK family(46) . Sidorenka et al.(55) demonstrated that Syk kinase associates with Lyn kinase in B-lineage lymphoid cells. Syk kinase has also been shown to mediate inositol trisphosphate generation in chicken B-lineage lymphoid cells, and Syk-deficient B-cells lack tyrosine phosphorylation of PLC2 resulting in the loss of calcium mobilization upon antigen receptor stimulation(45) . Therefore, we were compelled to study the effects of EMF exposure on the enzymatic activity of Syk kinase in B-lineage lymphoid cells. As shown in Fig. 3A, EMF exposure of NALM-6 human pre-B cells resulted in Syk kinase activation within 30 s, and maximum stimulation was observed at 1 min followed by rapid deactivation. At 20-30 min after EMF exposure, the Syk kinase activity was lower than at baseline (9-10 times 10^3 cpm versus 24 times 10^3 cpm; Fig. 3A). The enzymatic activity of Syk returned to baseline at 1 h. The abundance of the enzyme, as estimated by anti-Syk immunoblotting, did not change during the course of the experiment suggesting altered specific activity (Fig. 3B).


Figure 3: Time course of Syk kinase activation after EMF exposure. A, NALM-6 cells were exposed to 60-Hz EMF for the times indicated, pelleted, and lysed in Nonidet P-40 buffer. Syk kinase was immunoprecipitated and immune complex kinase assays (39) were performed using half of the samples, as described under ``Experimental Procedures.'' Autophosphorylation was quantitated by a 4-min liquid scintillation counting of the incorporated P in the the excised Syk kinase bands. B, the other half of the Syk immunoprecipitates were fractionated first on 9.5% polyacrylamide gels, electrophoretically transferred to Immobilon-polyvinylidene difluoride membranes and immunoblotted for 1 h with anti-Syk antibody (1:100 dilution) followed by incubation with I-protein A (specific activity = 30 µCi/µg; ICN Biomedicals) and autoradiography for detection of Syk.



EMF-induced Activation of Lyn Kinase Does Not Depend on Syk Kinase and Lyn Kinase Is Essential for EMF-induced Activation of Syk Kinase

In NALM-6 cells, Syk kinase activation was not as pronounced as Lyn kinase activation and it lasted less than 3 min, whereas Lyn kinase activation lasted at least 1 h (see Fig. 2and Fig. 3). These results implicated Lyn kinase in the induction of EMF-dependent tyrosine phosphorylation in B-lineage lymphoid cells. To directly evaluate the relative contributions of Lyn and Syk kinases to EMF-induced tyrosine phosphorylation, we used the DT-40 model system(45, 46) .

DT-40 is a chicken B-cell line that is immunobiologically and biochemically very similar to human B-lineage lymphoid progenitor cells (45, 46) . Like human B-lineage lymphoid cells that are thought to be the progenitors of leukemic cells in children with B-lineage ALL, DT-40 cells express high levels of Lyn and Syk tyrosine kinases but not the other members of the Src- or Syk-PTK families (see (45) and (46) and Fig. 4A). Lyn knock-out and Syk knock-out mutants of the DT-40 cell line were established by targeted gene disruption (see (45) and Fig. 4A). Defects of early signaling events are different between Lyn-deficient and Syk-deficient mutants, demonstrating that Lyn and Syk kinases mediate discrete signaling functions through their enzymatic activities(45) . As shown in Fig. 4B, EMF stimulated Lyn kinase activity in wild-type as well as Syk-deficient DT-40 cells. Furthermore, EMF exposure enhanced protein tyrosine phosphorylation in Syk-deficient but not in Lyn-deficient DT-40 cells (data not shown). Our results indicate that activation of Lyn kinase is sufficient and mandatory for EMF-induced tyrosine phosphorylation in DT-40 cells. However, these experiments in the DT-40 model system failed to provide conclusive information regarding the role of Lyn kinase in EMF-induced activation of Syk kinase because no significant Syk kinase stimulation was observed in wild-type DT-40 cells or Lyn-deficient DT-40 cells (data not shown).


Figure 4: EMF exposure stimulates Lyn kinase in wild-type as well as Syk kinase-deficient B-lineage lymphoid cells. A, unstimulated wild-type DT-40 chicken B cells (DT-40) as well as its Syk kinase deficient (DT-40) and Lyn kinase deficient (DT-40) mutants were lysed in a Nonidet P-40-containing buffer, and equal amounts of lysate (200 µg of protein/reaction mixture) were used for immunoprecipitation and immune complex kinase assays of Lyn, Blk, and Syk kinases, as described under ``Experimental Procedures.'' B, DT-40 and DT-40 were exposed to 60-Hz EMF for the times indicated, pelleted, and lysed in Nonidet P-40 buffer. Lyn kinase was immunoprecipitated, and immune complex kinase assays (39) were performed, as described under ``Experimental Procedures.''



Role of Tyrosine Phosphorylation in EMF-induced Activation of PKC in B-lineage Lymphoid Cells

Recent studies have demonstrated that stimulation of Src family PTK in B-lineage lymphoid cells is a requisite and proximal step in the activation of PKC and PKC-linked distal signaling events, including activation of nuclear factor kappaB and c-jun proto-oncogene expression after engagement of functionally important membrane receptors(39) , ionizing radiation(37, 38) , and UV radiation(56) . Therefore, we next examined the effects of tyrosine kinase inhibitors genistein and herbimycin on EMF-induced PKC activation in NALM-6 cells. As shown in Fig. 5, there was a marked EMF-induced increase in membrane-associated PKC activity which started at 5 min and continued for 60 min. Thus, PKC activity was stimulated much later than the activity of Lyn or Syk tyrosine kinases (see Fig. 2), suggesting that it may be triggered by tyrosine phosphorylation. Notably, treatment with herbimycin A (1 µg/ml times 18 h) or genistein (30 µg/ml times 30 min) prior to EMF exposure abrogated the EMF-induced PKC activation, providing evidence that stimulation of Src family PTK is an important and proximal step in EMF-induced activation of PKC in B-lineage lymphoid cells. These results are reminiscent of the role of tyrosine kinases in -ray- or B43(anti-CD19) antibody-induced activation of PKC in B-lineage lymphoid cells(37, 38, 39) .


Figure 5: PTK-dependent activation of PKC in B-lineage lymphoid cells exposed to EMF. NALM-6 human pre-B cells were exposed to EMF for the times indicated in the presence or absence of the PTK inhibitors herbimycin A (Herb) or genistein (Gen), as described under ``Experimental Procedures.'' Sham-treated controls (Sham) were incubated in the EMF exposure device, with current flowing in antiparallel directions to cancel out the generated magnetic field. Membrane-associated PKC activity was assayed, as detailed under ``Experimental Procedures.''



In summary, we examined the biochemical nature of signaling events in B-lineage lymphoid cells exposed to low energy EMF. This report clarifies the chronological sequence of biochemical events that follow EMF exposure and provides unprecedented evidence that EMF exposure initiates a signaling cascade that is intimately linked to the Src proto-oncogene family PTK Lyn. Lyn kinase participates and plays pivotal and myriad roles in initiation of signal cascades that affect proliferation and survival of B-lineage lymphoid cells(37, 38, 39) . Our observations prompt the hypothesis that a delicate growth-regulatory balance might be altered in B-lineage lymphoid cells by EMF-induced activation of Lyn.


FOOTNOTES

*
The project described was supported in part by Grant R01-ES-07175 from the NIEHS, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Stohlman Scholar of the Leukemia Society of America. To whom correspondence should be addressed: Biotherapy Program, University of Minnesota, 2685 Patton Rd., Roseville, MN 55113. Tel.: 612-627-1920; Fax: 612-627-1928.

(^1)
The abbreviations used are: ALL, acute lymphoblastic leukemia; PKC, protein kinase C; EMF, electromagnetic fields; PTK, protein tyrosine kinase.


REFERENCES

  1. Greaves, M. F. (1986) Science 234, 697-704 [Medline] [Order article via Infotrieve]
  2. Champlin, R., and Gale, R. P. (1989) Blood 73, 2051-2066 [Medline] [Order article via Infotrieve]
  3. Uckun, F. M. (1990) Blood 76, 1908-1923 [Medline] [Order article via Infotrieve]
  4. Wertheimer, N., and Leeper, E. (1979) Am. J. Epidemiol. 109, 273-284 [Abstract]
  5. Bastuka-Garin, S., Richardson, S., and Zittoun, R. (1990) Eur. J. Cancer 26, 1119-1120 [Medline] [Order article via Infotrieve]
  6. Bell, J., and Coleman, M. P. (1990) Br. J. Cancer 62, 331-332 [Medline] [Order article via Infotrieve]
  7. London, S. J., Thomas, D. C., Bowman, J. D., Sobel, E., and Peters, J. M. (1991) Am. J. Epidemiol. 134, 923-937 [Abstract]
  8. Savitz, D. A, John, E. M., and Kleckner, R. C. (1988) Am. J. Epidemiol. 131, 763-773 [Abstract]
  9. Savitz, D. A, Wachtel, H., Barnes, F. A., John, E. M., and Tvrdik, J. G. (1988) Am. J. Epidemiol. 128, 21-38 [Abstract]
  10. Fulton, J. P., Cobb, S., Preble, L., Leone, L., and Forman, E. (1980) Am. J. Epidemiol. 111, 292-296 [Abstract]
  11. Tomenius, L. (1986) Bioelectromagnetics 7, 191-207 [Medline] [Order article via Infotrieve]
  12. Easterly, C. E. (1981) Am. J. Epidemiol. 114, 169-174 [Medline] [Order article via Infotrieve]
  13. United States Environmental Protection Agency (1991) EPA Document 600/6-90/005A , Washington D. C.
  14. Feychting, M., and Ahlbom, A. (1992) Swedish National Institute for Occupational Health, IMM-rapport 6/92 , Swedish National Institute for Occupational Health, Stockholm
  15. Milham, S., Jr. (1988) Am. J. Epidemiol. 127, 50-54 [Abstract]
  16. McDowell, M. E. (1983) Lancet 1, 246-248
  17. Sheikh, K. (1986) Arch. Environ. Health. 41, 56-63 [Medline] [Order article via Infotrieve]
  18. Savitz, D. A., and Calle, E. E. (1989) Epidemiol. Rev. 11, 59-78 [Medline] [Order article via Infotrieve]
  19. Pool, R. (1990) Science 249, 1378-1381 [Medline] [Order article via Infotrieve]
  20. Wright, W. E., Peters, J. M., and Mack, T. M. (1982) Lancet 2, 1160-1171
  21. Adey, W. R. (1988) Neurochem. Res. 13, 671-675 [Medline] [Order article via Infotrieve]
  22. Liboff, A. R. (1985) J. Biol. Phys. 12, 99-102
  23. Adair, R. N. (1991) Phys. Rev. 43, 1039-1048 [CrossRef]
  24. Bennett, M. V. L., and Clusin, W. T. (1979) Membrane Transduction Mechanisms (Cone, R. A., and Dowling, J. E., eds) pp. 91-116, Raven Press, New York
  25. Kalmijn, A. J. (1984) Comparative Physiology of Sensory Systems (Bolis, L., Keynes, R. D., and Maddrell, S. H. P., eds) pp. 525-560, Cambridge University Press, Cambridge
  26. Anderson, L. E. (1991) Health Physics 61, 41-46 [Medline] [Order article via Infotrieve]
  27. Brown, H. D., and Chattopadhyay, S. K. (1988) Cancer Biochem. Biophys. 9, 295-342 [Medline] [Order article via Infotrieve]
  28. Adey, W. R. (1986) Bioelectrochem. Bioenerg. 15, 447-456 [CrossRef]
  29. Smith, O. M., Goodman, E. M., Greenebaum, B., and Tipnis, P. (1991) Bioelectromagnetics 12, 197-202 [Medline] [Order article via Infotrieve]
  30. Luben, R. A., and Cain, C. D. (1982) J. Electrochem. Soc. 128, 298-301
  31. Stuchly, M. A., Lecuyer, D. W., and McLean, J. (1991) Bioelectromagnetics 12, 261-272 [Medline] [Order article via Infotrieve]
  32. Cain, C. D., Adey, W. R., and Luben, R. A. (1987) J. Bone & Min. Res. 2, 437-441
  33. Luben, R. A. (1991) Health Physics 61, 15-28 [Medline] [Order article via Infotrieve]
  34. Luben, R. A., Morgan, A. P., Carlson, A., and Duong, M. (1993) Department of Energy Annual Review of Research on Biological Effects of Electric and Magnetic Fields, Savannah, GA, November 2, 1993 , Department of Energy, Washington D. C.
  35. Liburdy, R. P. (1992) FEBS Lett. 301, 53-59 [CrossRef][Medline] [Order article via Infotrieve]
  36. Uckun, F. M., Tuel-Ahlgren, L., Song, C. W., Waddick, K., Myers, D. E., Kirihara, J., Ledbetter, J. A., and Schieven, G. L. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9005-9009 [Abstract]
  37. Uckun, F. M., Tuel-Ahlgren, L., Schieven, G., Chae, H. P., Dibirdik, I., Smith, R., Myers, D. E., and Song, C. W. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 252-256 [Abstract]
  38. Chae, H. P., Jarvis, L., and Uckun, F. M. (1993) Cancer Res. 53, 447-451 [Abstract]
  39. Uckun, F. M., Burkhardt, A. L., Jarvis, L., Jun, X., Stealey, B., Dibirdik, I., Myers, D., Tuel-Ahlgren, L., and Bolen, J. B. (1993) J. Biol. Chem. 268, 21172-21184 [Abstract/Free Full Text]
  40. Waddick, K. G., Chae, H. P, Tuel-Ahlgren, L., Jarvis, L., Dibirdik, I., Myers, D. E., and Uckun, F. M. (1993) Radiat. Res. 136, 313-319 [Medline] [Order article via Infotrieve]
  41. Eiseman, E., and Bolen, J. B. (1990) Cancer Cells 2, 303-310 [Medline] [Order article via Infotrieve]
  42. Uckun, F. M., Evans, W. E., Forsyth, C. J., Waddick, K. G., Tuel-Ahlgren, L., Chelstrom, L. M., Burkhardt, A., Bolen, J., and Myers, D. E. (1995) Science 267, 886-891 [Medline] [Order article via Infotrieve]
  43. Bolen, J. B., Rowley, R., Spana, C., and Tsygankov, A. Y. (1992) FASEB J. 6, 3403-3409 [Abstract/Free Full Text]
  44. Hunter, T. (1991) Cell 64, 249-270 [Medline] [Order article via Infotrieve]
  45. Takata, M., Sabe, H., Hata, A., Inazu, T., Homma, Y., Nukada, T., Yamamura, H., and Kurosaki, T. (1994) EMBO J. 13, 1341-1349 [Abstract]
  46. Kurosaki, T., Takata, M., Yamanashi, Y., Inazu, T., Taniguchi, T., Yamamoto, T., and Yamamura, H. (1994) J. Exp. Med. 179, 1725-1729 [Abstract]
  47. Merritt, R., Purcell, C., and Stroink, G. (1983) Rev. Sci. Instrum. 54, 879-882 [CrossRef]
  48. Kirschvink, J. L. (1992) Bioelectromagnetics 13, 401-411 [Medline] [Order article via Infotrieve]
  49. Farrar, Y. J. K., Vanaman, T. C., and Slevin, J. T. (1991) Biochem. Biophys. Res. Commun. 180, 694-701 [Medline] [Order article via Infotrieve]
  50. Chakravarthy, B. R., Bussey, A., Whitfield, J. F., Sicorska, M., Williams, R. E., and Durkin, J. P. (1991) Anal. Biochem. 196, 144-150 [Medline] [Order article via Infotrieve]
  51. Uckun, F. M., Chelstrom, L. M., Finnegan, D., Tuel-Ahlgren, L., Manivel, C., Irvin, J. D., Myers, D. E., and Gunther, R. (1992) Blood 79, 3116-3129 [Abstract]
  52. Taniguchi, T., Kobayashi, T., Kondo, J., Takahashi, K., Nakamura, H., Suzuki, J., Nagai, K., Yamada, T., Nakamura, S., and Yamamura, H. (1991) J. Biol. Chem. 266, 15790-15796 [Abstract/Free Full Text]
  53. Hutchcroft, J. E., Harrison, M. L., and Geahlen, R. L. (1991) J. Biol. Chem. 266, 14846-14849 [Abstract/Free Full Text]
  54. Schieven, G. L., Kirihara, J. M., Burg, D. L., Geahlen, R. L., and Ledbetter, J. A. (1993) J. Biol. Chem. 268, 16688-16692 [Abstract/Free Full Text]
  55. Sidorenko, S. P., Law, C. L., Chandran, K. A., and Clark, E. A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 359-363 [Abstract]
  56. Devary, Y., Gottlieb, R. A., Smeal, T., and Karin, M. (1992) Cell 71, 1081-1091 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.